/ASTH
ASTH Stock - Astrana Health, Inc.
Healthcare|Medical - Care FacilitiesNASDAQ
$23.87+2.84%
+$0.66 (+2.84%) • Dec 19
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.15
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.85
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+27.1%upside
Target: $30.34
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ASTH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$23.63 – $24.11
TARGET (TP)$30.33
STOP LOSS$21.96
RISK/REWARD1:3.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.87
52W High$39.97
52W Low$20.12
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.03B | $1.39B | $1.14B | $773.91M | $370.25M |
| Gross Profit | $271.39M | $214.96M | $199.48M | $177.77M | $21.70M |
| Gross Margin | 13.3% | 15.5% | 17.4% | 23.0% | 5.9% |
| Operating Income | $89.35M | $84.61M | $104.27M | $98.18M | $6.09M |
| Net Income | $43.15M | $60.72M | $45.17M | $68.92M | $-23,752,000 |
| Net Margin | 2.1% | 4.4% | 3.9% | 8.9% | -6.4% |
| EPS | $0.91 | $1.30 | $1.00 | $1.57 | $1.04 |
Company Overview
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
5
83%
Hold / Neutral
1
17%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
5 Bullish1 Neutral/Bearish
Price Targets
$47
Average Target
↑ 98.3% Upside
Now
$28
Low
$47
Average
$66
High
Based on 6 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 12th 2025 | Needham | Initiation | Buy | $28 |
| April 1st 2025 | Barclays | Initiation | Equal Weight | $36 |
| October 14th 2024 | TD Cowen | Initiation | Buy | $66 |
| October 11th 2024 | KeyBanc Capital Markets | Initiation | Sector Weight | - |
| July 11th 2024 | Truist | Upgrade | Buy | $50← $44 |
| May 30th 2024 | Robert W. Baird | Initiation | Outperform | $54 |
| February 26th 2024 | Jefferies | Initiation | Buy | $50 |
Earnings History & Surprises
ASTHBeat Rate
60%
Last 15 quarters
Avg Surprise
-5.3%
EPS vs Estimate
Beats / Misses
9/6
Last 12 quarters
Latest EPS
$0.01
Q4 2025
EPS Surprise History
Q1 24
+73.3%
$0.26vs$0.15
Q2 24
+3.3%
$0.31vs$0.30
Q3 24
+2.6%
$0.40vs$0.39
Q4 24
+3.1%
$0.33vs$0.32
Q1 25
-168.2%
$-0.15vs$0.22
Q2 25
-39.1%
$0.14vs$0.23
Q3 25
-47.2%
$0.19vs$0.36
Q4 25
-97.9%
$0.01vs$0.47
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.16 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.47 | $0.01 | -97.9% | ✗ MISS |
Q3 2025 | Aug 7, 2025 | $0.36 | $0.19 | -47.2% | ✗ MISS |
Q2 2025 | May 8, 2025 | $0.23 | $0.14 | -39.1% | ✗ MISS |
Q1 2025 | Feb 27, 2025 | $0.22 | $-0.15 | -168.2% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $0.32 | $0.33 | +3.1% | ✓ BEAT |
Q3 2024 | Aug 7, 2024 | $0.39 | $0.40 | +2.6% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.30 | $0.31 | +3.3% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $0.15 | $0.26 | +73.3% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.27 | $0.47 | +74.1% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.25 | $0.28 | +13.0% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $0.31 | $0.28 | -8.8% | ✗ MISS |
Q4 2022 | Dec 30, 2022 | $-0.07 | $-0.06 | +20.3% | ✓ BEAT |
Q3 2022 | Sep 29, 2022 | $0.32 | $0.56 | +76.8% | ✓ BEAT |
Q2 2022 | Jun 29, 2022 | $0.20 | $0.25 | +22.0% | ✓ BEAT |
Q1 2022 | Mar 30, 2022 | — | $0.31 | — | — |
Q4 2021 | Dec 30, 2021 | $0.32 | $0.30 | -6.3% | ✗ MISS |
Q3 2021 | Sep 29, 2021 | — | $0.74 | — | — |
Q2 2021 | Jun 29, 2021 | — | $0.28 | — | — |
Latest News
Needham Initiates Coverage On Astrana Health with Buy Rating, Announces Price Target of $28
📈 PositiveBenzinga•Dec 12, 2025, 11:33 AM
Jefferies Maintains Buy on Astrana Health, Lowers Price Target to $37
➖ NeutralBenzinga•Nov 25, 2025, 07:48 PM•Also: ,
Barclays Maintains Equal-Weight on Astrana Health, Lowers Price Target to $26
📉 NegativeBenzinga•Nov 24, 2025, 02:21 PM•Also:
TD Cowen Maintains Buy on Astrana Health, Lowers Price Target to $35
➖ NeutralBenzinga•Nov 10, 2025, 05:32 PM
BTIG Maintains Buy on Astrana Health, Lowers Price Target to $45
📈 PositiveBenzinga•Nov 7, 2025, 07:38 PM
Astrana Health shares are trading lower after the company reported mixed Q3 financial results and narrowed its FY25 sales guidance below estimates.
📉 NegativeBenzinga•Nov 7, 2025, 02:19 PM
Astrana Health Narrows FY2025 Sales Guidance from $3.100B-$3.300B to $3.100B-$3.180B vs $3.209B Est
📉 NegativeBenzinga•Nov 6, 2025, 09:13 PM
Astrana Health Q3 EPS $0.01 Misses $0.41 Estimate, Sales $956.048M Beat $952.789M Estimate
📉 NegativeBenzinga•Nov 6, 2025, 09:12 PM
Frequently Asked Questions about ASTH
What is ASTH's current stock price?
Astrana Health, Inc. (ASTH) is currently trading at $23.87 per share. The stock has moved +2.84% today.
What is the analyst price target for ASTH?
The average analyst price target for ASTH is $30.33, based on 1 analyst.
What sector is Astrana Health, Inc. in?
Astrana Health, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is ASTH's market cap?
Astrana Health, Inc. has a market capitalization of $1.16 billion, making it a small-cap company.
Does ASTH pay dividends?
No, Astrana Health, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACHC
Acadia Healthcare Company, Inc.
$14.41
Mkt Cap: $1.3B
AVAH
Aveanna Healthcare Holdings Inc.
$9.09
Mkt Cap: $1.9B
HCSG
Healthcare Services Group, Inc.
$19.54
Mkt Cap: $1.4B
LFST
LifeStance Health Group, Inc.
$7.05
Mkt Cap: $2.7B
MD
Pediatrix Medical Group, Inc.
$21.91
Mkt Cap: $1.9B
MNKD
MannKind Corporation
$5.84
Mkt Cap: $1.8B
NHC
National HealthCare Corporation
$141.64
Mkt Cap: $2.2B
OMCL
Omnicell, Inc.
$46.84
Mkt Cap: $2.2B
SEM
Select Medical Holdings Corporation
$15.01
Mkt Cap: $1.9B
USPH
U.S. Physical Therapy, Inc.
$77.86
Mkt Cap: $1.2B
Explore stocks similar to ASTH for comparison